Pediatric antibiotics: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "8 mg" to "8mg") |
No edit summary |
||
| (31 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
= Neonatal Infections= | ==Neonatal Infections== | ||
*All doses are for patients >2 kg and at least 7 days of age | *All doses are for patients >2 kg and at least 7 days of age | ||
*Always treat for meningitis until you are sure it is not | *Always treat for meningitis until you are sure it is not | ||
==[[Pediatric fever of uncertain source]]== | ===[[Pediatric fever of uncertain source]]=== | ||
===Neonatal (0-28 days)=== | ===Neonatal (0-28 days)=== | ||
{{Pediatric fever antibiotics 0-28)}} | {{Pediatric fever antibiotics 0-28)}} | ||
| Line 23: | Line 23: | ||
==[[Osteomyelitis]]== | ==[[Osteomyelitis]]== | ||
*Empiric treatment: [[Nafcillin]] 200mg/kg/day IV div Q6 AND [[cefotaxime]] 150mg/kg/day IV div Q8 for >21 days. | |||
==[[UTI (peds)]]== | ==[[UTI (peds)]]== | ||
*<2 weeks: Ampicillin 100mg/kg/day IV div Q6 (or Q12 if <7 days) AND | *<2 weeks: [[Ampicillin]] 100mg/kg/day IV div Q6 (or Q12 if <7 days) AND [[gentamicin]] 3mg/kg/day IV Q24 OR [[cefotaxime]] 150mg/kg/day IV div Q8 | ||
*2 weeks - 2 months: Ampicillin 100mg/kg/day IV div Q6 AND | *2 weeks - 2 months: [[Ampicillin]] 100mg/kg/day IV div Q6 AND [[cefotaxime]] 150mg/kg/day div Q8 | ||
==[[Neonatal conjunctivitis]]== | ==[[Neonatal conjunctivitis]]== | ||
| Line 40: | Line 40: | ||
|- | |- | ||
| rowspan="2" | Septic shock syndromes | | rowspan="2" | Septic shock syndromes | ||
| | | [[Bacteremia]]: ''[[S. pneumo]], [[N. meningitidis]], [[H. influenzae]]'' (if not immunized) | ||
| rowspan="1" | Replete intravascular volume, maximize delivery of oxygen to tissues. Blood cultures. [[Ceftriaxone]] 50mg/kg/day IV/IM Q24 or Cefotaxime 150mg/kg/day IV div Q8 until afebrile x24 hours. | | rowspan="1" | Replete intravascular volume, maximize delivery of oxygen to tissues. Blood cultures. [[Ceftriaxone]] 50mg/kg/day IV/IM Q24 or [[Cefotaxime]] 150mg/kg/day IV div Q8 until afebrile x24 hours. | ||
|- | |- | ||
| Toxic shock | | [[Toxic shock syndrome]]: ''Staphylococcal ''(less often associated with deep tissue disease), ''Streptococcal'' | ||
| rowspan="1" | | | rowspan="1" | | ||
'''Empiric therapy should include | '''Empiric therapy should include [[clindamycin]] and [[beta-lactam]] until etiology is isolated.''' | ||
'''Staphylococcal: '''Most often associated with toxin-producing organism at a mucosal site, may involved disease at a deeper site. Associated with tampon use, wound infection or burns. 5-15% case fatality rate. Rx: Nafcillin AND clindamycin | '''[[Staphylococcal]]: '''Most often associated with toxin-producing organism at a mucosal site, may involved disease at a deeper site. Associated with tampon use, wound infection or burns. 5-15% case fatality rate. Rx: [[Nafcillin]] AND [[clindamycin]] initially. Substitute [[cefazolin]] or [[vancomycin]] for nafcillin if MRSA suspected. [[IVIG]] 1 g/kg may bind toxins, but should be reserved for life-threatening infections. | ||
'''Streptococcal: '''Invasive disease at a deep site is the rule; deep site infection should be sought aggressively and treated. Defined as isolation of ''GAS'', hypotension, renal impairment, coagulopathy, ARDS and soft tissue necrosis. Associated with | '''[[Streptococcal]]: '''Invasive disease at a deep site is the rule; deep site infection should be sought aggressively and treated. Defined as isolation of ''GAS'', hypotension, renal impairment, coagulopathy, ARDS and soft tissue necrosis. Associated with erysipelas, [[Necrotizing Fascitis]], secondary infection of varicella. Rx: Once streptococcus is identified, change therapy to [[penicillin]] or other [[ß-lactam]] antibiotic PLUS Clindamycin. | ||
|- | |- | ||
| rowspan="2" | Central line infection | | rowspan="2" | [[Central line]] infection | ||
| ''Coagulase-negative Staph (CONS), S. aureus, GN-bacilli, Candida spp.'' | | ''Coagulase-negative Staph (CONS), [[S. aureus]], GN-bacilli, [[Candida]] spp.'' | ||
| rowspan="1" | | | rowspan="1" | | ||
'' | ''Coagulase-negative Staph (CONS)'': can try to salvage catheter with 10-14 days of therapy ([[vancomycin]]), 80% cure rate for exit site infections, 25% if deeper. | ||
If ''S. aureus'', ''[[Gram-Negative]] bacilli'' or ''Candida'': always remove the catheter if possible. ''S. aureus ''has a 10% exit site cure rate and 0% deeper infection cure rate if catheter left in. | If ''[[S. aureus]]'', ''[[Gram-Negative]] bacilli'' or ''[[Candida]]'': always remove the catheter if possible. ''S. aureus ''has a 10% exit site cure rate and 0% deeper infection cure rate if catheter left in. | ||
If septic thrombophlebitis, [[endocarditis]], [[osteomyelitis]] or repeated positive cultures, ALWAYS remove catheter. | If septic thrombophlebitis, [[endocarditis]], [[osteomyelitis]] or repeated positive cultures, ALWAYS remove catheter. | ||
| Line 63: | Line 63: | ||
|- | |- | ||
| TPN/Intralipids: as above and ''Malassezia furfur'' | | TPN/Intralipids: as above and ''Malassezia furfur'' | ||
| rowspan="1" | Remove catheter and discontinue antimicrobials if possible. If ''Candida albicans'', treat with Fluconazole 6-12mg/kg/day IV Q24 (if | | rowspan="1" | Remove catheter and discontinue antimicrobials if possible. If ''[[Candida albicans]]'', treat with [[Fluconazole]] 6-12mg/kg/day IV Q24 (if >14 days old) x 28 days OR conventional [[Amphotericin B]] 1mg/kg/day IV div Q24. If ''[[Staph epidermidis]]'', treat with [[vancomycin]] and discontinue intralipids. If ''M. furfur'', treat with conventional [[Amphotericin B]]. | ||
|- | |- | ||
| [[Fever and Neutropenia]] | | [[Fever and Neutropenia]] | ||
| ''Aerobic GNR, Strep | | ''Aerobic GNR, [[Strep viridans]], MRSA'' | ||
| | | | ||
Piperacillin- | [[Piperacillin-tazobactam]] 400mg/kg/day IV div Q6 OR [[Ceftzidime]] 150mg/kg/day IV div Q8 OR [[Meropenem]] 60mg/kg/day IV div Q8. Consider adding [[gentamicin]] if persistently ill-appearing. Consider adding [[vancomycin]] if MRSA or coagulase-negative Staph suspected. | ||
Consider adding | Consider adding [[amphotericin B]] 1mg/kg/day IV Q24 if persistently febrile >5 days on antibiotics. Consider [[meropenem]] alone or addition of [[metronidazole]] if [[typhlitis]] suspected. | ||
|- | |- | ||
| Line 76: | Line 76: | ||
| ''[[Borrelia burgdorferi]]'' | | ''[[Borrelia burgdorferi]]'' | ||
| | | | ||
Early rash (erythema migrans), carditic, facial nerve palsy, [[meningitis]]/[[encephalitis]], arthritis. | Early rash (erythema migrans), carditic, facial nerve palsy, [[meningitis]]/[[encephalitis]], [[arthritis]]. | ||
*Early localized/disseminated disease: | *Early localized/disseminated disease: [[doxycycline]] 4mg/kg/day PO div BID (if >7 yo) OR [[amoxicillin]] 50mg/kg/day PO (max 1.5 g/day) div TID x14-21 days. Alternative [[erythromycin]] 30mg/kg/day IV div Q8. | ||
*Arthritis (no CNS disease): As above x28 days.<br> | *Arthritis (no CNS disease): As above x28 days.<br> | ||
*[[Bell's Palsy]]: As above x21-28 days.<br> | *[[Bell's Palsy]]: As above x21-28 days.<br> | ||
*Neuroborreliosis (CNS): [[ceftriaxone]] 75-100mg/kg/day IV Q24 OR | *Neuroborreliosis (CNS): [[ceftriaxone]] 75-100mg/kg/day IV Q24 OR [[penicillin G]] 300,000 U/kg/day IV div Q4 x14-21 days.<br> | ||
|- | |- | ||
| Line 89: | Line 89: | ||
Suspect if fever, rash (95%), petechiae spreading from distal to central. Confirm with antibody titers. Ticks most often in Mid-Atlantic states. Treat empirically and aggressively, can be fatal. | Suspect if fever, rash (95%), petechiae spreading from distal to central. Confirm with antibody titers. Ticks most often in Mid-Atlantic states. Treat empirically and aggressively, can be fatal. | ||
#Doxycycline 4mg/kg/day PO div BID x7-10 days (recommend for all age groups).<br> | #[[Doxycycline]] 4mg/kg/day PO div BID x7-10 days (recommend for all age groups).<br> | ||
|- | |- | ||
| Line 97: | Line 97: | ||
Suspect if febrile, flu-like illness with rash in April-Sept. Leukopenia and thrombocytopenia common. 80% have positive blood smear (HGE only). Dx HME with PCR. Confirm with DFA. Commonly co-infected with ''B. burgdorferi<u></u>''. | Suspect if febrile, flu-like illness with rash in April-Sept. Leukopenia and thrombocytopenia common. 80% have positive blood smear (HGE only). Dx HME with PCR. Confirm with DFA. Commonly co-infected with ''B. burgdorferi<u></u>''. | ||
# | #[[Doxycycline]] 4mg/kg/day PO div BID x7 days.<br> | ||
|} | |} | ||
| Line 118: | Line 118: | ||
==[[Mastoiditis]], acute== | ==[[Mastoiditis]], acute== | ||
''S. pneumo ''(22%), ''S. pyogenes ''(16%), ''S. aureus ''(7%), ''H. flu, P. aeruginosa'' | ''S. pneumo ''(22%), ''S. pyogenes ''(16%), ''S. aureus ''(7%), ''H. flu, P. aeruginosa'' | ||
R/O [[meningitis]]. Surgical debridement as indicated. Transition to PO once clinically improved. Ampicillin- | R/O [[meningitis]]. Surgical debridement as indicated. Transition to PO once clinically improved. [[Ampicillin-sulbactam]] 300mg/kg/dau IV div Q6 OR [[cefotaxime]] 150mg/kg/day div Q8 OR [[ceftriaxone]] 50mg/kg/day Q24 +/- [[nafcillin]] 200mg/kg/day IV div Q6 OR [[clindamycin]] 40mg/kg/day IV div Q6 or [[vancomycin]] x21 days. | ||
==[[Sinusitis]], acute== | ==[[Sinusitis]], acute== | ||
#Amoxicillin 90mg/kg/day x14-21 days.<br> | #[[Amoxicillin]] 90mg/kg/day x14-21 days.<br> | ||
#Augmentin, | #[[Augmentin]], [[cefuroxime]] or [[cefdinir]] if recent antibiotics or chronic sinusitis. | ||
==[[Conjunctivitis]]== | ==[[Conjunctivitis]]== | ||
*Adenovirus (types 3, 7) | *[[Adenovirus]] (types 3, 7) | ||
**AKA pink eye. No treatment needed. Highly contagious. Cold artificial tears may help. NEVER treat with steroids except by an ophthalmologist! | **AKA pink eye. No treatment needed. Highly contagious. Cold artificial tears may help. NEVER treat with steroids except by an ophthalmologist! | ||
*[[HSV]] types 1-2 | *[[HSV]] types 1-2 | ||
| Line 132: | Line 132: | ||
**Vidarbine ophthalmic ointment Q3 until 1 weeks after healthing. | **Vidarbine ophthalmic ointment Q3 until 1 weeks after healthing. | ||
*''S. pneumo, H. flu'' | *''S. pneumo, H. flu'' | ||
** | **Polymyxin/trimethoprim ophthalmic solution 1 drop Q3 OR polymixin.bacitracin/Neosporin ophthalmic solution 1 drop Q3 x7-10 days. | ||
==[[Dacryocystitis ]]== | ==[[Dacryocystitis ]]== | ||
Warm compresses and tear duct massage. No antimicrobial therapy usually needed. Oral antimicrobial therapy for more symptomatic infections | *Warm compresses and tear duct massage. No antimicrobial therapy usually needed. Oral antimicrobial therapy for more symptomatic infections | ||
==[[Orbital Cellulitis]]== | ==[[Orbital Cellulitis]]== | ||
Ampicillin- | *[[Ampicillin-sulbactam]] 300mg/kg/day IV div Q6 OR [[cefotaxime]] 150mg/kg/day div Q8 OR [[ceftriaxone]] 50mg/kg/day Q24 AND [[nafcillin]] 200mg/kg/day IV div Q6. If any MRSA isolated locally, add [[clindamycin]] 40mg/kg/day IV div Q6 OR [[vancomycin]] x10-14 days. | ||
==[[Periorbital Cellulitis|Periorbital (preseptal) Cellulitis]]== | ==[[Periorbital Cellulitis|Periorbital (preseptal) Cellulitis]]== | ||
#If known entry site: | #If known entry site: [[nafcillin]] 200mg/kg/day IV div Q6 OR [[cefazolin]] 100mg/kg/day IV Q8 x7-10 days. If MRSA suspected, [[Vancomycin]] OR [[clindamycin]] 40mg/kg/day IV div Q6. Oral antistaphylococcal antibiotics for less severe infections. | ||
#Periorbital swelling without cellulitis (often associated with sinusitis): [[Ceftriaxone]] 50mg/kg/day IV Q24 OR | #Periorbital swelling without cellulitis (often associated with sinusitis): [[Ceftriaxone]] 50mg/kg/day IV Q24 OR [[cefotaxime]] 150mg/kg/day IV div Q8. ADD [[clindamycin]] 40mg/kg/day IV div Q6 for more severe infections of suspicion of MRSA. See 'Head: Sinusitis' for oral therapy options. | ||
==[[Otitis Externa]]== | ==[[Otitis Externa]]== | ||
*Clean canal often. | *Clean canal often. | ||
*Neomycin/Polymixin B +/- hydrocortisone otic drops. Alternate: Ofloxacin or | *[[Hydrocortisone/neomycin/polymyxin|Neomycin/Polymixin B +/- hydrocortisone]] otic drops. Alternate: [[Ofloxacin]] or [[ciprofloxacin]] solution. For 'swimmers ear' use VoSol (2% acetic acid) to canal. | ||
*Candidal: Fluconazole 5-10mg/kg/day PO Q24 x5-7 days. | *Candidal: [[Fluconazole]] 5-10mg/kg/day PO Q24 x5-7 days. | ||
==[[Otitis Media]]== | ==[[Otitis Media]]== | ||
'''Note: '''If >2 years, afebrile, no otalgia, borderline exam → consider | '''Note: '''If >2 years, afebrile, no otalgia, borderline exam → consider symptomatic treatment or safety net antibiotic prescription (SNAP). | ||
#Amoxicillin 80-90mg/kg/day div BID or TID x10 days ( | #[[Amoxicillin]] 80-90mg/kg/day div BID or TID x10 days (<2 years) or x5 days (>2 years). | ||
#Augmentin 90mg/kg/day | #[[Augmentin]] 90mg/kg/day amoxicillin component div BID. | ||
#Cefdinir | #[[Cefdinir]], [[cefpodoxime]], [[cefprozil]], [[cefuroxime]]. [[Azithromycin]] (up to 40% resistance in PRSP). | ||
==[[Ludwig's Angina]]== | ==[[Ludwig's Angina]]== | ||
High risk of respiratory tract obstruction due to inflammatory edema. | High risk of respiratory tract obstruction due to inflammatory edema. | ||
#Penicillin G 200,000 U/kg/day div Q6 AND | #[[Penicillin G]] 200,000 U/kg/day div Q6 AND [[clindamycin]] 40mg/kg/day IV vid Q6. | ||
#Consider | #Consider | ||
[[meropenem]], [[piperacillin-tazobactam]] OR [[ceftriaxone]] if [[GNR]] suspected. | |||
==[[Dental abscess]]== | ==[[Dental abscess]]== | ||
#Clindamycin 40mg/kg/day PO/IV/IM div Q6 or | #[[Clindamycin]] 40mg/kg/day PO/IV/IM div Q6 or [[Penicillin G]] 100,000-200,000 U/kg/day IV div Q6. | ||
==[[Gingivostomatitis]]== | ==[[Gingivostomatitis]]== | ||
Acyclovir PO 80mg/kg/day div Q6 x7 days. For severe disease can use Acyclovir 30mg/kg/day IV div Q8. | *[[Acyclovir]] PO 80mg/kg/day div Q6 x7 days. For severe disease can use Acyclovir 30mg/kg/day IV div Q8. | ||
==[[Bacterial tracheitis]]== | ==[[Bacterial tracheitis]]== | ||
#([[Vancomycin OR | #([[Vancomycin]] OR [[clindamycin]] 40mg/kg/day div Q6) AND ([[Cefotaxime]] 150mg/kg/day div Q8 OR [[ceftriaxone]] 50mg/kg/day Q24). Tailor to cultures. | ||
#Cefuroxime 100-150mg/kg/day div Q8. | #[[Cefuroxime]] 100-150mg/kg/day div Q8. | ||
==[[Epiglottitis]]== | ==[[Epiglottitis]]== | ||
Cefotaxime 150mg/kg/day div Q8 OR [[ceftriaxone]] 50mg/kg/day Q24. ADD Clindamycin 40mg/kg/day IV div Q6 OR [[vancomycin]] if Staph suspected. | *[[Cefotaxime]] 150mg/kg/day div Q8 OR [[ceftriaxone]] 50mg/kg/day Q24. ADD Clindamycin 40mg/kg/day IV div Q6 OR [[vancomycin]] if Staph suspected. | ||
==[[Pharyngitis]]== | ==[[Pharyngitis]]== | ||
Throat: Culture before treating. ''GAS'' uncommon in children | *Throat: Culture before treating. ''GAS'' uncommon in children <3 years. Treatment decrease rheumatic fever 2.8 to 0.2%. Rx as below also for scarlet fever. | ||
#Penicillin V 25-50mg/kg/day PO div TID-QID OR | #[[Penicillin]] V 25-50mg/kg/day PO div TID-QID OR [[amoxicillin]] 50-75mg/kg/day div BID-TID x10 days. | ||
# | #[[Penicillin G]] Benzathine 600,000 U IM (<27 kg), 1.2 million U (>27 kg) x1. | ||
#Erythromycin or | #[[Erythromycin]] or [[clindamycin]] for PCN-allergic patients. | ||
= Respiratory Tract Infections = | = Respiratory Tract Infections = | ||
| Line 187: | Line 188: | ||
==[[Whooping cough]]== | ==[[Whooping cough]]== | ||
#Erythromycin ethyl succinate 40mg/kg/day PO div QID x14 days (max 2000mg/day). Note: Do not use erythromycin base, which causes excessive GI symptoms. | #[[Erythromycin]] ethyl succinate 40mg/kg/day PO div QID x14 days (max 2000mg/day). Note: Do not use erythromycin base, which causes excessive GI symptoms. | ||
#Azithromycin ( | #[[Azithromycin]] (<6 months): 10mg/kg once daily x5 days (max 500mg). Note: Preferred agent for patients <1 month. | ||
==Cardiovascular Infections == | ==Cardiovascular Infections== | ||
===[[Endocarditis]]=== | ===[[Endocarditis]]=== | ||
'''Prophylaxis indications''' | '''Prophylaxis indications''' | ||
| Line 198: | Line 198: | ||
Previous infectious endocarditis. | Previous infectious endocarditis. | ||
Congenital heart disease (CHD) - except for the conditions listed below, antibiotic prophylaxis is no longer recommended for any other form of CHD. | [[Congenital heart disease]] (CHD) - except for the conditions listed below, antibiotic prophylaxis is no longer recommended for any other form of CHD. | ||
*Unrepaired cyanotic CHD, including palliative shunts and conduits. | *Unrepaired cyanotic CHD, including palliative shunts and conduits. | ||
*Completely repaired CHD with prosthetic material or device, whether placed by surgery or by catheter | *Completely repaired CHD with prosthetic material or device, whether placed by surgery or by catheter intervention, during the first 6 months after the procedure. | ||
*Repaired CHD with residual defects at the site or adjacent to the site or a prosthetic patch or prosthetic device (which inhibit | *Repaired CHD with residual defects at the site or adjacent to the site or a prosthetic patch or prosthetic device (which inhibit endothelialization). | ||
Cardiac transplantation recipients who develop cardiac valvulopathy. | Cardiac transplantation recipients who develop cardiac valvulopathy. | ||
'''Prophylaxis for oral, dental, respiratory tract or high risk patients with chronic GI/GU infections ''' | '''Prophylaxis for oral, dental, respiratory tract or high risk patients with chronic GI/GU infections ''' | ||
#Amoxicillin 50mg/kg PO x1 OR Ampicillin 50mg/kg IV x1, 30-60 minutes prior to the procedure. | #[[Amoxicillin]] 50mg/kg PO x1 OR Ampicillin 50mg/kg IV x1, 30-60 minutes prior to the procedure. | ||
#Allergic patients: Clindamycin 20mg/kg PO/IV x1 OR [[cephalexin]] 50mg/kg PO x1 OR | #Allergic patients: [[Clindamycin]] 20mg/kg PO/IV x1 OR [[cephalexin]] 50mg/kg PO x1 OR [[azithromycin]] 15mg/kg PO x1. | ||
'''Empiric therapy, native valves: S. | '''Empiric therapy, native valves: S. viridans, Enterococci, Staphylococci''' | ||
By definition includes multiple positive [[blood cultures]], new murmur of valvular insufficiency, emboli and echo evidence of vegetations. Send cultures and target therapy based on results. [[Vancomycin]] and Gentamicin pending culture results. | By definition includes multiple positive [[blood cultures]], new murmur of valvular insufficiency, emboli and echo evidence of vegetations. Send cultures and target therapy based on results. [[Vancomycin]] and Gentamicin pending culture results. | ||
==Gastroenterologic Infections == | ==Gastroenterologic Infections== | ||
{| cellspacing="0" cellpadding="2" border="1" align="left" | {| cellspacing="0" cellpadding="2" border="1" align="left" | ||
| Line 220: | Line 220: | ||
| rowspan="7" | [[Diarrhea]] | | rowspan="7" | [[Diarrhea]] | ||
| colspan="2" | | | colspan="2" | | ||
'''Initial Workup:''' If blood diarrhea or | '''Initial Workup:''' If blood diarrhea or >6 stools/day and febrile then consider stool cultures, fecal leukocytes, electrolytes. | ||
'''Isolation:''' Contact precautions for diapered or incontinent children. | '''Isolation:''' Contact precautions for diapered or incontinent children. | ||
| Line 229: | Line 229: | ||
Suspect if blood diarrhea, cramping develop with recent antibiotic exposure. | Suspect if blood diarrhea, cramping develop with recent antibiotic exposure. | ||
#Metronidazole 30mg/kg/day PO/IV div QID x10 days. | #[[Metronidazole]] 30mg/kg/day PO/IV div QID x10 days. | ||
#[[Vancomycin]] 40mg/kg/day PO | #[[Vancomycin]] 40mg/kg/day PO;div QID x10 days ONLY for Metronidazole failures. | ||
|- | |- | ||
| Line 237: | Line 237: | ||
Suspect if prominent abdominal pain. Young infants may only have bloody diarrhea. Can have immunoreactive complications such as AIDP, reactive arthritis, Reiter syndrome or erythema nodosum. | Suspect if prominent abdominal pain. Young infants may only have bloody diarrhea. Can have immunoreactive complications such as AIDP, reactive arthritis, Reiter syndrome or erythema nodosum. | ||
#Erythromycin 40mg/kg/day PO div QID x5 days. Shortens duration of illness and prevents relapse if given early | #[[Erythromycin]] 40mg/kg/day PO div QID x5 days. Shortens duration of illness and prevents relapse if given early. | ||
|- | |- | ||
| | | | ||
''E. coli O157:H7'' | ''[[E. coli]] O157:H7'' | ||
''(Enterotoxin producing, ETEC)'' | ''(Enterotoxin producing, ETEC)'' | ||
| Suspect if bloody diarrhea, | | Suspect if bloody diarrhea, >6 unformed stools/day and afebrile. Causes 36% of bloody diarrhea. Consider CBC and blood smear. If no hemolysis, azotemia or thrombocytopenia after 3 days of illness, risk of developing HUS is low. Antimicrobial therapy may precipitate an adverse reaction.<br> | ||
|- | |- | ||
| ''Salmonella''<br> | | ''[[Salmonella]]''<br> | ||
| | | | ||
May cause asymptomatic disease, gastroenteritis, bacteremia, osteomyelitis or meningitis. Exposures to lizards and other reptiles may result in unusual species of ''Salmonella''. | May cause asymptomatic disease, gastroenteritis, bacteremia, osteomyelitis or meningitis. Exposures to lizards and other reptiles may result in unusual species of ''Salmonella''. | ||
#Antimicrobial therapy increases duration of illness in most carriers.<br> | #Antimicrobial therapy increases duration of illness in most carriers.<br> | ||
#Therapy recommended if invasive or focal disease, if | #Therapy recommended if invasive or focal disease, if <3 months old, chronic GI disease, oncology patients, hemoglobinopathies, or HIV+. May treat with [[amoxicillin]] or [[TMP-SMX]]; [[Ceftriaxone]] for neonates (not receiving calcium containing fluids) or septic clinical state.<br> | ||
|- | |- | ||
| ''Shigella''<br> | | ''[[Shigella]]''<br> | ||
| | | | ||
Suspect if fever, cramps, tenesmus, abdominal pain. Complications include seizures, bacteremia, Reiter Syndrome, HUS (''S. dystenteriae | Suspect if fever, cramps, tenesmus, abdominal pain. Complications include seizures, bacteremia, Reiter Syndrome, HUS (''S. dystenteriae;''type 1), toxic megacolon and toxic encephalopathy (ekiri syndrome). | ||
#Cefixime 8mg/kg/day PO div BID or [[TMP-SMX]] | #[[Cefixime]] 8mg/kg/day PO div BID or [[TMP-SMX]] 8mg/kg/day TMP PO div TID x5-7 days. Illness usually self-limited (48-72 hours), but treatment is always indicated to decrease duration of shedding, which is important for public health measures.<br> | ||
|- | |- | ||
| ''Yersinia enterocolitica''<br> | | ''[[Yersinia enterocolitica]]''<br> | ||
| Causes mesenteric adenitis, mimics appendicitis. Predisposed by iron overload states (chronic transfusions). Antimicrobial therapies not indicated in normal hosts.<br> | | Causes mesenteric adenitis, mimics appendicitis. Predisposed by iron overload states (chronic transfusions). Antimicrobial therapies not indicated in normal hosts.<br> | ||
|- | |- | ||
| Line 271: | Line 270: | ||
Bacteremia in 30-50% of cases. Definitive antimicrobial therapy based on culture results. ''B. fragilis ''invades gut after several days of age. | Bacteremia in 30-50% of cases. Definitive antimicrobial therapy based on culture results. ''B. fragilis ''invades gut after several days of age. | ||
#Ampicillin AND | #[[Ampicillin]] AND [[gentamicin]] x10 or more days<br> | ||
Consider adding | Consider adding [[cefotaxime]] if CNS involvement cannot be excluded. Consider replacing [[ampicillin]] with [[vancomycin]] if MRSA/CONS. Consider adding [[clindamycin]] if perforation cannot be excluded.<br> | ||
|- | |- | ||
| Line 279: | Line 278: | ||
| ''Enteric GNR, Bacteroides sp., Enterococcus sp.''<br> | | ''Enteric GNR, Bacteroides sp., Enterococcus sp.''<br> | ||
| | | | ||
#Meropenem 60mg/kg/day IV div Q8 OR | #[[Meropenem]] 60mg/kg/day IV div Q8 OR [[piperacillin-tazobactam]] 400mg/kg/day IV div Q6 x7-10 days.<br> | ||
#Ampicillin 150mg/kg/day IV div Q8 AND | #[[Ampicillin]] 150mg/kg/day IV div Q8 AND [[gentamicin]] (dose per age) IV div Q8 AND [[clindamycin]] 40mg/kg/day IV Q6 OR [[metronidazole]] 30mg/kg/day IV div Q6] x7-10 days.<br> | ||
|- | |- | ||
| Peritonitis (peritoneal dialysis)<br> | | Peritonitis (peritoneal dialysis)<br> | ||
| ''Staphylococci, GNs, ''yeast<br> | | ''Staphylococci, GNs, ''yeast<br> | ||
| Antibiotic added to dialysate in concentrations approximating those attained in serum for systemic disease | | Antibiotic added to dialysate in concentrations approximating those attained in serum for systemic disease [[gentamicin]] 8mg/L, [[Vancomycin]] 50mg/L).<br> | ||
|} | |} | ||
==Genitourinary Infections== | ==Genitourinary Infections== | ||
===[[Pyelonephritis]]=== | ===[[Pyelonephritis]]=== | ||
Inpatient: Ceftriaxone 50mg/kg/day IV/IM Q24 OR | Inpatient: [[Ceftriaxone]] 50mg/kg/day IV/IM Q24 OR [[gentamicin]] (age based dosing) OR [[TMP/SMX] 8mg/kg/day IV div BID x14 days. Treat IV until defervesces and clinically improved, then transition to PO. | ||
Outpatient: TMP-SMX | Outpatient: [[TMP-SMX]] OR [[cefixime]] OR [[ciprofloxacin]] (in adolescents); see doses under UTI | ||
===[[UTI]]=== | ===[[UTI]]=== | ||
'''Inpatient: '''>2 months: | '''Inpatient: '''>2 months: [[cefotaxime]] or [[ceftriaxone]] until taking PO, well appearing → transition to outpatient therapy. | ||
'''Outpatient: '''(Infants and Children): TMP-SMX | '''Outpatient: '''(Infants and Children): [[TMP-SMX]] 6-10mg/kg/day TMP component div BID OR [[cefixime]] 16mg/kg/day x1 day, then 8mg/kg/day Q24 (max 400mg/dose) OR [[cephalexin]] 25mg/kg/dose QID (max 1000mg/dose) x7-14 days. Alternatives: [[nitrofurantoin]], [[ciprofloxacin]], [[ceftriaxone]]. <br> | ||
==Skin & Soft Tissue Infections<br> == | ==Skin & Soft Tissue Infections<br>== | ||
===[[ | ===Skin [[abscess]]=== | ||
*OSSA/MSSA - [[Cephalexin]] 50-75mg/kg/day PO div TID OR Augmentin 80-90mg/kg/day PO div BID x5-7 days. '''I&D when indicated.'''<br> | *OSSA/MSSA - [[Cephalexin]] 50-75mg/kg/day PO div TID OR [[Augmentin]] 80-90mg/kg/day PO div BID x5-7 days. '''I&D when indicated.'''<br> | ||
*If MRSA prevalent or if recurrent abscess, send specimen for culture and sensitivity. Treat with | *If MRSA prevalent or if recurrent abscess, send specimen for culture and sensitivity. Treat with [[clindamycin]] 40mg/kg/day IV div Q6 or [[TMP-SMX]] 5mg/kg/dose TMP Q6-8. If toxic-appearing, use [[vancomycin]]. | ||
===[[Cellulitis]]=== | ===[[Cellulitis]]=== | ||
Start IV: Clindamycin 40mg/kg/day IV div Q6 if high community incidence of MRSA. May use | *Start IV: [[Clindamycin]] 40mg/kg/day IV div Q6 if high community incidence of MRSA. May use [[nafcillin]] 200mg/kg/day IV div Q6 OR [[cefazolin]] 100mg/kg/day IV div Q8 if low incidence of MRSA. Transition to PO when stable. If no improvement, change to [[vancomycin]] (dose by age). | ||
PO: [[Cephalexin]] 50-75mg/kg/day divided TID OR | *PO: [[Cephalexin]] 50-75mg/kg/day divided TID OR [[dicloxacillin]] 50mg/kg/day PO div Q6. Total duration of treatment 7-10 days. | ||
===[[Erysipelas]]=== | ===[[Erysipelas]]=== | ||
Penicillin G IV, then transition to | *[[Penicillin G]] IV, then transition to [[penicillin]] V or [[amoxicillin]] PO;x10 days.<br> | ||
===[[Impetigo]]=== | ===[[Impetigo]]=== | ||
*Mupirocin topical to lesions TID, cleanse with soap and water. Bathe daily. If extensive, treat with [[ | *[[Mupirocin]] topical to lesions TID, cleanse with soap and water. Bathe daily. If extensive, treat with [[cephalexin]] PO or [[amoxicillin-clavulanate]] x5-7 days. | ||
===Omphalitis/Funisitis=== | ===Omphalitis/Funisitis=== | ||
Empiric: Cefotaxime AND | *Empiric: [[Cefotaxime]] AND [[clindamycin]] x10 or more days. | ||
Funisitis (local infection of cord): cord care, topical antimicrobials. | *Funisitis (local infection of cord): cord care, topical antimicrobials. | ||
===[[Paronychia]]=== | ===[[Paronychia]]=== | ||
*Local wound care and I&D unless signs of spreading infection, then consider Augmentin or | *Local wound care and I&D unless signs of spreading infection, then consider [[Augmentin]] or [[clindamycin]]. | ||
===[[Scabies]]=== | ===[[Scabies]]=== | ||
#Topical 5% | #Topical 5% [[permethrin]] cream, apply to neck down, wash off in 8-14 hours.<br> | ||
#Topical Lindane 1% | #Topical Lindane 1%- ''Avoid unless treatment failure to permethrin due to risk of neurotoxicity. Many contraindications/precautions!'' | ||
===[[Staphylococcal scalded skin syndrome]]=== | |||
#[[Nafcillin]] 200mg/kg/day IV div Q6 OR Cefazolin IV x5-7 days. Consider [[vancomycin]]. | |||
Avoid TMP-SMX. | Avoid TMP-SMX. | ||
===[[Tinea corporis]]=== | ===[[Tinea corporis]]=== | ||
May use one of many topical antifungal agents: Terbinafine 1% cream or gel BID to affected areas; | *May use one of many topical antifungal agents: [[Terbinafine]] 1% cream or gel BID to affected areas; [[clotrimazole]] 1% cream, lotion or solution; others include Econazole, Sulconazole, Oxiconazole, Naftifine, Cicloprox, Ketoconazole, Sertaconazle, Moconazole and Tolnaftate. Treat for 14 days. Keep affected areas dry.<br> | ||
===[[Tinea capitis]]=== | ===[[Tinea capitis]]=== | ||
Griseofulvin Microsize 10-20mg/kg/day div Q12-24 (max 1000mg/day) OR | *[[Griseofulvin]] Microsize 10-20mg/kg/day div Q12-24 (max 1000mg/day) OR [[Griseofulvin]] Ultramicrosize >2 years 5-10mg/kg/day div Q12-24 x6 weeks] AND [[Selenium sulfide]] shampoo twice weekly x1 week as directed. | ||
===[[Necrotizing Fasciitis]]=== | ===[[Necrotizing Fasciitis]]=== | ||
#Prompt surgical debridement and cultures. Send for cultures and | #Prompt surgical debridement and cultures. Send for cultures and sensitivities.<br> | ||
#Treat with | #Treat with [[clindamycin]] AND [[Zosyn]] OR [[cefotaxime]]. For proven streptococcal disease, [[penicillin]] and [[clindamycin]] suffice. | ||
| Line 424: | Line 349: | ||
Treat all bat and feral cat exposures with both HRIG and [[Rabies]] vaccine as below. Otherwise, treat with vaccine and contact public health officials or infection control for advice on whether to treat with HRIG. Monitor animal for 10 days. | Treat all bat and feral cat exposures with both HRIG and [[Rabies]] vaccine as below. Otherwise, treat with vaccine and contact public health officials or infection control for advice on whether to treat with HRIG. Monitor animal for 10 days. | ||
#[[Rabies]] vaccine 1 mL | #[[Rabies]] vaccine 1 mL;IM into deltoid days 0, 3, 7, 14 and 28. | ||
#HRIG 20 IU/kg around wound and begin vaccination series with HDCV or | #HRIG 20 IU/kg around wound and begin vaccination series with HDCV or;RVA vaccine days 0, 3, 7, 14 and 28. | ||
#Consider treating with Augmentin as below. | #Consider treating with Augmentin as below. | ||
| Line 433: | Line 358: | ||
| Cat: ''Pasteurella multocida, S. aureus''<br> | | Cat: ''Pasteurella multocida, S. aureus''<br> | ||
| | | | ||
#Augmentin 45mg/kg/day div Q8-12 x5-7 days. For | #[[Augmentin]] 45mg/kg/day div Q8-12 x5-7 days. For penicillin allergic patients, ''Pasteurella ''is covered by [[doxycycline]] or [[ciprofloxacin]]. Add another drug for ''Strep;''or ''Staph sp.'' | ||
#Rabies: See above if feral cat. Check tetanus status. | #Rabies: See above if feral cat. Check tetanus status. | ||
| Line 439: | Line 364: | ||
| Dog: ''Pasteurella multocida, S. aureu''''s, Bacteroides, Fusobacterium, Capnophaga'''''<b><br></b> | | Dog: ''Pasteurella multocida, S. aureu''''s, Bacteroides, Fusobacterium, Capnophaga'''''<b><br></b> | ||
| | | | ||
#Augmentin 45mg/kg/day PO div Q8-12 x5-7 days<br> | #[[Augmentin]] 45mg/kg/day PO div Q8-12 x5-7 days<br> | ||
#Rabies: see above. Check tetanus status. | #Rabies: see above. Check tetanus status. | ||
|- | |- | ||
| Human: ''Strep viridans | | Human: ''Strep viridans;''(100%), ''Staph epinephrine ''(53%), ''Cornybacterium ''(41%), ''S. aureus ''(29%), ''Eikenella, Bacteroides, Peptostrep''<br> | ||
| | | | ||
High rates of infection. '''Do not close open wounds!''' | High rates of infection. '''Do not close open wounds!''' | ||
#Early (no signs of infection): Augmentin 45mg/kg/day PO div Q8-12 x5-7 days. | #Early (no signs of infection): [[Augmentin]] 45mg/kg/day PO div Q8-12 x5-7 days. | ||
#Late (signs of infection): Ampicillin- | #Late (signs of infection): [[Ampicillin-sulbactam]] IV. Can use [[clindamycin]] AND [[ampicillin]]. | ||
#Check tetanus status. | #Check tetanus status. | ||
| Line 454: | Line 379: | ||
| Rat or pig (polymicrobial, ''Sprillum minus'', ''Streptobacillus'')<br> | | Rat or pig (polymicrobial, ''Sprillum minus'', ''Streptobacillus'')<br> | ||
| | | | ||
#Augmentin 45mg/kg/day PO div Q8-12 x5-7 days<br> | #[[Augmentin]] 45mg/kg/day PO div Q8-12 x5-7 days<br> | ||
#Rabies: see above. Check tetanus status. | #Rabies: see above. Check tetanus status. | ||
|- | |- | ||
| rowspan="2" | Lymphadenitis<br> | | rowspan="2" | Lymphadenitis<br> | ||
| Localized infection: ''GAS, S. aureus (MRSA)...less likely anaerobes, M. Tb ''(scrofula), ''Toxoplasmosis, Tularemia, Sporotrichosis, | | Localized infection: ''GAS, S. aureus (MRSA)...less likely anaerobes, M. Tb ''(scrofula), ''Toxoplasmosis, Tularemia, Sporotrichosis,;''atypical mycobacterial (consider the latter if nonresponsive to antimicrobials)<br> | ||
| | | | ||
MSSA: Augmentin 90mg/kg/day PO div BID OR [[Cephalexin]] 100mg/kg/day PO div QID x10 days. If IV needed, | MSSA: [[Augmentin]] 90mg/kg/day PO div BID OR [[Cephalexin]] 100mg/kg/day PO div QID x10 days. If IV needed, [[cefazolin]] 100mg/kg/day IV div Q8. | ||
MRSA: Clindamycin OR TMP-SMX OR | MRSA: [[Clindamycin]] OR [[TMP-SMX]] OR [[linezolid]] OR [[vancomycin]] (age based dosing) x7-10 days total. | ||
|- | |- | ||
| Cat-scratch disease: ''Bartonella henslae''<br> | | Cat-scratch disease: ''Bartonella henslae''<br> | ||
| | | | ||
Lymphadenitis common in axillary/epitrochlear nodes (46%), neck (26%), inguinal (17%). Treat for | Lymphadenitis common in axillary/epitrochlear nodes (46%), neck (26%), inguinal (17%). Treat for immunocompromised host of signs of systemic illness;(HSM). | ||
#Azithromycin 10mg/kg/day PO Q24 x5 days. | #[[Azithromycin]] 10mg/kg/day PO Q24 x5 days. | ||
May also use [[Bactrim]], | May also use [[Bactrim]], [[rifampin]] and [[ciprofloxacin]]. Duration of therapy is uncertain. | ||
|} | |} | ||
==Orthopedic Infections == | ==Orthopedic Infections== | ||
===[[Osteomyelitis]]=== | ===[[Osteomyelitis]]=== | ||
{{Osteomyelitis Antibiotics}} | {{Osteomyelitis Antibiotics}} | ||
===[[Septic Arthritis]]=== | ===[[Septic Arthritis]]=== | ||
*If immunized against ''Hib'': Nafcillin 200mg/kg/day IV div Q6 OR | *If immunized against ''Hib'': [[Nafcillin]] 200mg/kg/day IV div Q6 OR [[cefazolin]] 100mg/kg/day div Q8 x21 days. | ||
*If unimmunized again ''Hib'': Cefuroxime OR [ | *If unimmunized again ''Hib'': [[Cefuroxime]] OR [[cefotaxime]] AND [[nafcillin]] OR [[cefazolin]] x21 days. | ||
*If ''[[Gonococcus]]'' suspected or isolated, [[ceftriaxone]] 50mg/kg/day IV/IM daily OR | *If ''[[Gonococcus]]'' suspected or isolated, [[ceftriaxone]] 50mg/kg/day IV/IM daily OR [[penicillin G]] IV (if susceptible) x7-10 days. | ||
==See Also== | ==See Also== | ||
{{Antibiotics by diagnosis navigation}} | {{Antibiotics by diagnosis navigation}} | ||
=References= | ==References== | ||
<references/> | <references/> | ||
[[Category:ID]] [[Category:Pharmacology]] [[Category:Pediatrics]] | [[Category:ID]] [[Category:Pharmacology]] [[Category:Pediatrics]] | ||
Latest revision as of 23:07, 16 May 2020
Neonatal Infections
- All doses are for patients >2 kg and at least 7 days of age
- Always treat for meningitis until you are sure it is not
Pediatric fever of uncertain source
Neonatal (0-28 days)
- If <14 days, Ampicillin 50 mg/kg/dose AND (Gentamicin 4 mg/kg/dose or Cefepime 30mg/kg/dose)
- If >14 days, Ampicillin 50 mg/kg/dose AND Ceftriaxone^^ 50-100mg/kg/dose
- Acyclovir^ 20 mg/kg/dose
^Acyclovir if:
Neonatal (28-90 days)
- Ampicillin 50 mg/kg/dose AND Ceftriaxone^^ 50-100mg/kg
- Acyclovir^ 20 mg/kg
^Acyclovir if:
Meningitis
MRSA is uncommon in the neonate
- Ampicillin 75mg/kg IV q6hrs PLUS
- Cefotaxime 50mg/kg IV q6hrs OR Gentamicin 2.5mg/kg IV q8hrs
- Per AAP, ceftazidime 50mg/kg IV (q12hr for babies < 8 days of age, q8hr for >7 days old) is a reasonable alternative to cefotaxime, offering virtually the same coverage for enteric bacilli and is FDA approved for all age groups[1]
- If suspecting S. pneumoniae or MRSA, add Vancomycin
- Consider acyclovir for HSV
- Acyclovir 20 mg/kg IV every 8 hours (duration depends on classification)
- If ocular involvement:
- 1% trifluridine, 0.1% iododeoxyuridine, or 3% vidarabine
- Optho consult
- As for any febrile neonate SBI evaluation:
- Ampicillin + gentamycin
- May substitute gentamycin with cefotaxime/ceftazidime
- Ampicillin + gentamycin
Pneumonia (peds)
Newborn
- Hospitalized[2]
- Ampicillin (80-90mg/kg/day) + gentamicin +/- cefotaxime
- Add vancomycin if MRSA a concern
- Add erythromycin (12.g mg/kg QID) if concern for chlamydia
- Ampicillin (80-90mg/kg/day) + gentamicin +/- cefotaxime
- Outpatient[3]
- Initial outpatient management not recommended
1-3 Month
- Hospitalized[4]
- Afebrile pneumonitis
- Erythromycin (10 mg/kg q6) or Azithromycin (2.5 mg/kg q12)
- Febrile pneumonia
- Add Cefotaxime (200mg/kg per day divided q8h)
- Afebrile pneumonitis
- Outpatient[5]
- Erythromycin OR Azithromycin PO
>3mo - 18 years
- Hospitalized (PICU/severely ill)[6]
- Ceftriaxone IV AND Vancomycin AND consider Azithromycin
- Hospitalized (moderately ill)[7]
- Fully immunized: Ampicillin (50mg/kg q6) IV
- Not fully immunized: Ceftriaxone IV
- Outpatient[8]
- Amoxicillin (90 mg/kg divided BID) x 10 days PO
- Some studies have shown that 5 day course may also be adequate treatment
- Alternative: Clindamycin OR Azithromycin OR Amoxicillin-clavulanate
- Amoxicillin (90 mg/kg divided BID) x 10 days PO
Osteomyelitis
- Empiric treatment: Nafcillin 200mg/kg/day IV div Q6 AND cefotaxime 150mg/kg/day IV div Q8 for >21 days.
UTI (peds)
- <2 weeks: Ampicillin 100mg/kg/day IV div Q6 (or Q12 if <7 days) AND gentamicin 3mg/kg/day IV Q24 OR cefotaxime 150mg/kg/day IV div Q8
- 2 weeks - 2 months: Ampicillin 100mg/kg/day IV div Q6 AND cefotaxime 150mg/kg/day div Q8
Neonatal conjunctivitis
Prophylaxis
- Erythromycin 0.5% ointment x1 or tetracycline 1% or silver nitrate 1% x1 topical (rarely used because of its potential for causing chemical conjunctivitis), applied at birth.
Chemical
- Watchful waiting
Gonococcal (onset 2-4 days)
- Cefotaxime 100mg/kg IV or IM OR ceftriaxone 25-50mg/kg IV or IM x1 (not to exceed 125mg)
- Cefotaxime is preferred because it does not displace bilirubin
- Disseminated disease should be suspected until CSF is negative
- Treat mother and partners
- Irrigate eyes with saline (topical antibiotics are insufficient and unnecessary)
Chlamydia (onset 5-10 days)
- Erythromycin ophthalmic ointment plus one of the following
- Azithromycin 20mg/kg PO once daily x 3 days OR
- Erythromycin 50mg/kg PO QD in 4 divided doses x 14 days
- Disease manifests 5 days post-birth to 2 weeks (late onset)
Herpetic (onset 6-14 days)
- Acyclovir 20mg/kg IV q8hr x 14-21d
- Topical antiviral
- Do not give steroids
- Full neonatal sepsis evaluation
- Immediate ophtho consult
Febrile Syndromes/Bloodstream Infections
Pediatric fever of uncertain source (90 days - 36 months)
- Ceftriaxone (50-100mg/kg/dose) AND
- Consider vancomycin (15mg/kg)^^^^
| Septic shock syndromes | Bacteremia: S. pneumo, N. meningitidis, H. influenzae (if not immunized) | Replete intravascular volume, maximize delivery of oxygen to tissues. Blood cultures. Ceftriaxone 50mg/kg/day IV/IM Q24 or Cefotaxime 150mg/kg/day IV div Q8 until afebrile x24 hours. |
| Toxic shock syndrome: Staphylococcal (less often associated with deep tissue disease), Streptococcal |
Empiric therapy should include clindamycin and beta-lactam until etiology is isolated. Staphylococcal: Most often associated with toxin-producing organism at a mucosal site, may involved disease at a deeper site. Associated with tampon use, wound infection or burns. 5-15% case fatality rate. Rx: Nafcillin AND clindamycin initially. Substitute cefazolin or vancomycin for nafcillin if MRSA suspected. IVIG 1 g/kg may bind toxins, but should be reserved for life-threatening infections. Streptococcal: Invasive disease at a deep site is the rule; deep site infection should be sought aggressively and treated. Defined as isolation of GAS, hypotension, renal impairment, coagulopathy, ARDS and soft tissue necrosis. Associated with erysipelas, Necrotizing Fascitis, secondary infection of varicella. Rx: Once streptococcus is identified, change therapy to penicillin or other ß-lactam antibiotic PLUS Clindamycin. | |
| Central line infection | Coagulase-negative Staph (CONS), S. aureus, GN-bacilli, Candida spp. |
Coagulase-negative Staph (CONS): can try to salvage catheter with 10-14 days of therapy (vancomycin), 80% cure rate for exit site infections, 25% if deeper. If S. aureus, Gram-Negative bacilli or Candida: always remove the catheter if possible. S. aureus has a 10% exit site cure rate and 0% deeper infection cure rate if catheter left in. If septic thrombophlebitis, endocarditis, osteomyelitis or repeated positive cultures, ALWAYS remove catheter. |
| TPN/Intralipids: as above and Malassezia furfur | Remove catheter and discontinue antimicrobials if possible. If Candida albicans, treat with Fluconazole 6-12mg/kg/day IV Q24 (if >14 days old) x 28 days OR conventional Amphotericin B 1mg/kg/day IV div Q24. If Staph epidermidis, treat with vancomycin and discontinue intralipids. If M. furfur, treat with conventional Amphotericin B. | |
| Fever and Neutropenia | Aerobic GNR, Strep viridans, MRSA |
Piperacillin-tazobactam 400mg/kg/day IV div Q6 OR Ceftzidime 150mg/kg/day IV div Q8 OR Meropenem 60mg/kg/day IV div Q8. Consider adding gentamicin if persistently ill-appearing. Consider adding vancomycin if MRSA or coagulase-negative Staph suspected. Consider adding amphotericin B 1mg/kg/day IV Q24 if persistently febrile >5 days on antibiotics. Consider meropenem alone or addition of metronidazole if typhlitis suspected. |
| Lyme Disease | Borrelia burgdorferi |
Early rash (erythema migrans), carditic, facial nerve palsy, meningitis/encephalitis, arthritis.
|
| Rocky Mountain Spotted Fever | Rickettsia ricketsii |
Suspect if fever, rash (95%), petechiae spreading from distal to central. Confirm with antibody titers. Ticks most often in Mid-Atlantic states. Treat empirically and aggressively, can be fatal.
|
| Ehrlichiosis | Ehrlichia chaffensis or phagocytophilum |
Suspect if febrile, flu-like illness with rash in April-Sept. Leukopenia and thrombocytopenia common. 80% have positive blood smear (HGE only). Dx HME with PCR. Confirm with DFA. Commonly co-infected with B. burgdorferi.
|
CNS Infections
Meningitis (peds)
Treatment guidelines based on van de Beek et al[9]
Neonates (up to 1 month of age)
MRSA is uncommon in the neonate
- Ampicillin 75mg/kg IV q6hrs PLUS
- Cefotaxime 50mg/kg IV q6hrs OR Gentamicin 2.5mg/kg IV q8hrs
- Per AAP, ceftazidime 50mg/kg IV (q12hr for babies < 8 days of age, q8hr for >7 days old) is a reasonable alternative to cefotaxime, offering virtually the same coverage for enteric bacilli and is FDA approved for all age groups[10]
- If suspecting S. pneumoniae or MRSA, add Vancomycin
- Consider acyclovir for HSV
> 1 month old
- Ceftriaxone 2gm (50mg/kg) IV BID daily PLUS
- Vancomycin 15-20 mg/kg IV BID daily
- Vancomycin is for resistant Pneumococcus
VP shunt infections
- Empiric therapy: Vancomycin AND Cefotaxime 200 mg/kg/day IV div Q6 OR ceftriaxone 100 mg/kg/day IV div Q12-24
- Always involved neurosurgery in management
- Tailor antimicrobial therapy to culture results
Head, Eyes, Ears, Nose & Throat Infections
Mastoiditis, acute
S. pneumo (22%), S. pyogenes (16%), S. aureus (7%), H. flu, P. aeruginosa R/O meningitis. Surgical debridement as indicated. Transition to PO once clinically improved. Ampicillin-sulbactam 300mg/kg/dau IV div Q6 OR cefotaxime 150mg/kg/day div Q8 OR ceftriaxone 50mg/kg/day Q24 +/- nafcillin 200mg/kg/day IV div Q6 OR clindamycin 40mg/kg/day IV div Q6 or vancomycin x21 days.
Sinusitis, acute
- Amoxicillin 90mg/kg/day x14-21 days.
- Augmentin, cefuroxime or cefdinir if recent antibiotics or chronic sinusitis.
Conjunctivitis
- Adenovirus (types 3, 7)
- AKA pink eye. No treatment needed. Highly contagious. Cold artificial tears may help. NEVER treat with steroids except by an ophthalmologist!
- HSV types 1-2
- Can be sight-threatening. Refer to ophthalmologist immediately! 30-50% recurrence in 2 years.
- Trifluridine OR idoxuridine ophthalmic solution 1 drop Q2-3 while awake x7-14 days.
- Vidarbine ophthalmic ointment Q3 until 1 weeks after healthing.
- S. pneumo, H. flu
- Polymyxin/trimethoprim ophthalmic solution 1 drop Q3 OR polymixin.bacitracin/Neosporin ophthalmic solution 1 drop Q3 x7-10 days.
Dacryocystitis
- Warm compresses and tear duct massage. No antimicrobial therapy usually needed. Oral antimicrobial therapy for more symptomatic infections
Orbital Cellulitis
- Ampicillin-sulbactam 300mg/kg/day IV div Q6 OR cefotaxime 150mg/kg/day div Q8 OR ceftriaxone 50mg/kg/day Q24 AND nafcillin 200mg/kg/day IV div Q6. If any MRSA isolated locally, add clindamycin 40mg/kg/day IV div Q6 OR vancomycin x10-14 days.
Periorbital (preseptal) Cellulitis
- If known entry site: nafcillin 200mg/kg/day IV div Q6 OR cefazolin 100mg/kg/day IV Q8 x7-10 days. If MRSA suspected, Vancomycin OR clindamycin 40mg/kg/day IV div Q6. Oral antistaphylococcal antibiotics for less severe infections.
- Periorbital swelling without cellulitis (often associated with sinusitis): Ceftriaxone 50mg/kg/day IV Q24 OR cefotaxime 150mg/kg/day IV div Q8. ADD clindamycin 40mg/kg/day IV div Q6 for more severe infections of suspicion of MRSA. See 'Head: Sinusitis' for oral therapy options.
Otitis Externa
- Clean canal often.
- Neomycin/Polymixin B +/- hydrocortisone otic drops. Alternate: Ofloxacin or ciprofloxacin solution. For 'swimmers ear' use VoSol (2% acetic acid) to canal.
- Candidal: Fluconazole 5-10mg/kg/day PO Q24 x5-7 days.
Otitis Media
Note: If >2 years, afebrile, no otalgia, borderline exam → consider symptomatic treatment or safety net antibiotic prescription (SNAP).
- Amoxicillin 80-90mg/kg/day div BID or TID x10 days (<2 years) or x5 days (>2 years).
- Augmentin 90mg/kg/day amoxicillin component div BID.
- Cefdinir, cefpodoxime, cefprozil, cefuroxime. Azithromycin (up to 40% resistance in PRSP).
Ludwig's Angina
High risk of respiratory tract obstruction due to inflammatory edema.
- Penicillin G 200,000 U/kg/day div Q6 AND clindamycin 40mg/kg/day IV vid Q6.
- Consider
meropenem, piperacillin-tazobactam OR ceftriaxone if GNR suspected.
Dental abscess
- Clindamycin 40mg/kg/day PO/IV/IM div Q6 or Penicillin G 100,000-200,000 U/kg/day IV div Q6.
Gingivostomatitis
- Acyclovir PO 80mg/kg/day div Q6 x7 days. For severe disease can use Acyclovir 30mg/kg/day IV div Q8.
Bacterial tracheitis
- (Vancomycin OR clindamycin 40mg/kg/day div Q6) AND (Cefotaxime 150mg/kg/day div Q8 OR ceftriaxone 50mg/kg/day Q24). Tailor to cultures.
- Cefuroxime 100-150mg/kg/day div Q8.
Epiglottitis
- Cefotaxime 150mg/kg/day div Q8 OR ceftriaxone 50mg/kg/day Q24. ADD Clindamycin 40mg/kg/day IV div Q6 OR vancomycin if Staph suspected.
Pharyngitis
- Throat: Culture before treating. GAS uncommon in children <3 years. Treatment decrease rheumatic fever 2.8 to 0.2%. Rx as below also for scarlet fever.
- Penicillin V 25-50mg/kg/day PO div TID-QID OR amoxicillin 50-75mg/kg/day div BID-TID x10 days.
- Penicillin G Benzathine 600,000 U IM (<27 kg), 1.2 million U (>27 kg) x1.
- Erythromycin or clindamycin for PCN-allergic patients.
Respiratory Tract Infections
Pneumonia
Newborn
- Hospitalized[11]
- Ampicillin (80-90mg/kg/day) + gentamicin +/- cefotaxime
- Add vancomycin if MRSA a concern
- Add erythromycin (12.g mg/kg QID) if concern for chlamydia
- Ampicillin (80-90mg/kg/day) + gentamicin +/- cefotaxime
- Outpatient[12]
- Initial outpatient management not recommended
1-3 Month
- Hospitalized[13]
- Afebrile pneumonitis
- Erythromycin (10 mg/kg q6) or Azithromycin (2.5 mg/kg q12)
- Febrile pneumonia
- Add Cefotaxime (200mg/kg per day divided q8h)
- Afebrile pneumonitis
- Outpatient[14]
- Erythromycin OR Azithromycin PO
>3mo - 18 years
- Hospitalized (PICU/severely ill)[15]
- Ceftriaxone IV AND Vancomycin AND consider Azithromycin
- Hospitalized (moderately ill)[16]
- Fully immunized: Ampicillin (50mg/kg q6) IV
- Not fully immunized: Ceftriaxone IV
- Outpatient[17]
- Amoxicillin (90 mg/kg divided BID) x 10 days PO
- Some studies have shown that 5 day course may also be adequate treatment
- Alternative: Clindamycin OR Azithromycin OR Amoxicillin-clavulanate
- Amoxicillin (90 mg/kg divided BID) x 10 days PO
Whooping cough
- Erythromycin ethyl succinate 40mg/kg/day PO div QID x14 days (max 2000mg/day). Note: Do not use erythromycin base, which causes excessive GI symptoms.
- Azithromycin (<6 months): 10mg/kg once daily x5 days (max 500mg). Note: Preferred agent for patients <1 month.
Cardiovascular Infections
Endocarditis
Prophylaxis indications Prosthetic cardiac valve or prosthetic material used for cardiac valve repair.
Previous infectious endocarditis.
Congenital heart disease (CHD) - except for the conditions listed below, antibiotic prophylaxis is no longer recommended for any other form of CHD.
- Unrepaired cyanotic CHD, including palliative shunts and conduits.
- Completely repaired CHD with prosthetic material or device, whether placed by surgery or by catheter intervention, during the first 6 months after the procedure.
- Repaired CHD with residual defects at the site or adjacent to the site or a prosthetic patch or prosthetic device (which inhibit endothelialization).
Cardiac transplantation recipients who develop cardiac valvulopathy.
Prophylaxis for oral, dental, respiratory tract or high risk patients with chronic GI/GU infections
- Amoxicillin 50mg/kg PO x1 OR Ampicillin 50mg/kg IV x1, 30-60 minutes prior to the procedure.
- Allergic patients: Clindamycin 20mg/kg PO/IV x1 OR cephalexin 50mg/kg PO x1 OR azithromycin 15mg/kg PO x1.
Empiric therapy, native valves: S. viridans, Enterococci, Staphylococci
By definition includes multiple positive blood cultures, new murmur of valvular insufficiency, emboli and echo evidence of vegetations. Send cultures and target therapy based on results. Vancomycin and Gentamicin pending culture results.
Gastroenterologic Infections
| Diarrhea |
Initial Workup: If blood diarrhea or >6 stools/day and febrile then consider stool cultures, fecal leukocytes, electrolytes. Isolation: Contact precautions for diapered or incontinent children. | |
| C. difficile |
Suspect if blood diarrhea, cramping develop with recent antibiotic exposure.
| |
| C. jejuni |
Suspect if prominent abdominal pain. Young infants may only have bloody diarrhea. Can have immunoreactive complications such as AIDP, reactive arthritis, Reiter syndrome or erythema nodosum.
| |
|
E. coli O157:H7 (Enterotoxin producing, ETEC) |
Suspect if bloody diarrhea, >6 unformed stools/day and afebrile. Causes 36% of bloody diarrhea. Consider CBC and blood smear. If no hemolysis, azotemia or thrombocytopenia after 3 days of illness, risk of developing HUS is low. Antimicrobial therapy may precipitate an adverse reaction. | |
| Salmonella |
May cause asymptomatic disease, gastroenteritis, bacteremia, osteomyelitis or meningitis. Exposures to lizards and other reptiles may result in unusual species of Salmonella.
| |
| Shigella |
Suspect if fever, cramps, tenesmus, abdominal pain. Complications include seizures, bacteremia, Reiter Syndrome, HUS (S. dystenteriae;type 1), toxic megacolon and toxic encephalopathy (ekiri syndrome). | |
| Yersinia enterocolitica |
Causes mesenteric adenitis, mimics appendicitis. Predisposed by iron overload states (chronic transfusions). Antimicrobial therapies not indicated in normal hosts. | |
| Necrotizing Enterocolitis (NEC) | Multifactorial disease, including bacterial invasion (debated). E. coli, Klebsiella, Pseudomonas, Clostridial sp., S. aureus, B. fragilis. |
Bacteremia in 30-50% of cases. Definitive antimicrobial therapy based on culture results. B. fragilis invades gut after several days of age.
Consider adding cefotaxime if CNS involvement cannot be excluded. Consider replacing ampicillin with vancomycin if MRSA/CONS. Consider adding clindamycin if perforation cannot be excluded. |
| Peritonitis (bowel perforation or appendicitis) |
Enteric GNR, Bacteroides sp., Enterococcus sp. |
|
| Peritonitis (peritoneal dialysis) |
Staphylococci, GNs, yeast |
Antibiotic added to dialysate in concentrations approximating those attained in serum for systemic disease gentamicin 8mg/L, Vancomycin 50mg/L). |
Genitourinary Infections
Pyelonephritis
Inpatient: Ceftriaxone 50mg/kg/day IV/IM Q24 OR gentamicin (age based dosing) OR [[TMP/SMX] 8mg/kg/day IV div BID x14 days. Treat IV until defervesces and clinically improved, then transition to PO.
Outpatient: TMP-SMX OR cefixime OR ciprofloxacin (in adolescents); see doses under UTI
UTI
Inpatient: >2 months: cefotaxime or ceftriaxone until taking PO, well appearing → transition to outpatient therapy.
Outpatient: (Infants and Children): TMP-SMX 6-10mg/kg/day TMP component div BID OR cefixime 16mg/kg/day x1 day, then 8mg/kg/day Q24 (max 400mg/dose) OR cephalexin 25mg/kg/dose QID (max 1000mg/dose) x7-14 days. Alternatives: nitrofurantoin, ciprofloxacin, ceftriaxone.
Skin & Soft Tissue Infections
Skin abscess
- OSSA/MSSA - Cephalexin 50-75mg/kg/day PO div TID OR Augmentin 80-90mg/kg/day PO div BID x5-7 days. I&D when indicated.
- If MRSA prevalent or if recurrent abscess, send specimen for culture and sensitivity. Treat with clindamycin 40mg/kg/day IV div Q6 or TMP-SMX 5mg/kg/dose TMP Q6-8. If toxic-appearing, use vancomycin.
Cellulitis
- Start IV: Clindamycin 40mg/kg/day IV div Q6 if high community incidence of MRSA. May use nafcillin 200mg/kg/day IV div Q6 OR cefazolin 100mg/kg/day IV div Q8 if low incidence of MRSA. Transition to PO when stable. If no improvement, change to vancomycin (dose by age).
- PO: Cephalexin 50-75mg/kg/day divided TID OR dicloxacillin 50mg/kg/day PO div Q6. Total duration of treatment 7-10 days.
Erysipelas
- Penicillin G IV, then transition to penicillin V or amoxicillin PO;x10 days.
Impetigo
- Mupirocin topical to lesions TID, cleanse with soap and water. Bathe daily. If extensive, treat with cephalexin PO or amoxicillin-clavulanate x5-7 days.
Omphalitis/Funisitis
- Empiric: Cefotaxime AND clindamycin x10 or more days.
- Funisitis (local infection of cord): cord care, topical antimicrobials.
Paronychia
- Local wound care and I&D unless signs of spreading infection, then consider Augmentin or clindamycin.
Scabies
- Topical 5% permethrin cream, apply to neck down, wash off in 8-14 hours.
- Topical Lindane 1%- Avoid unless treatment failure to permethrin due to risk of neurotoxicity. Many contraindications/precautions!
Staphylococcal scalded skin syndrome
- Nafcillin 200mg/kg/day IV div Q6 OR Cefazolin IV x5-7 days. Consider vancomycin.
Avoid TMP-SMX.
Tinea corporis
- May use one of many topical antifungal agents: Terbinafine 1% cream or gel BID to affected areas; clotrimazole 1% cream, lotion or solution; others include Econazole, Sulconazole, Oxiconazole, Naftifine, Cicloprox, Ketoconazole, Sertaconazle, Moconazole and Tolnaftate. Treat for 14 days. Keep affected areas dry.
Tinea capitis
- Griseofulvin Microsize 10-20mg/kg/day div Q12-24 (max 1000mg/day) OR Griseofulvin Ultramicrosize >2 years 5-10mg/kg/day div Q12-24 x6 weeks] AND Selenium sulfide shampoo twice weekly x1 week as directed.
Necrotizing Fasciitis
- Prompt surgical debridement and cultures. Send for cultures and sensitivities.
- Treat with clindamycin AND Zosyn OR cefotaxime. For proven streptococcal disease, penicillin and clindamycin suffice.
| Animal bites | Rabies prone: BATS, feral cats, raccoon, skunk, foxes, coyotes, most carnivores, woodchucks and livestock in certain areas |
Treat all bat and feral cat exposures with both HRIG and Rabies vaccine as below. Otherwise, treat with vaccine and contact public health officials or infection control for advice on whether to treat with HRIG. Monitor animal for 10 days.
|
| Non Rabies-prone: Rodents, rabbits, hares, squirrels, hamsters, guinea pigs, gerbils, rats, chipmunks and mice usually do not require anti-rabies therapy. Consult public health officials with concerns. Check tetanus status. Consider Augmentin as below. | ||
| Cat: Pasteurella multocida, S. aureus |
| |
| Dog: Pasteurella multocida, S. aureu's, Bacteroides, Fusobacterium, Capnophaga |
| |
| Human: Strep viridans;(100%), Staph epinephrine (53%), Cornybacterium (41%), S. aureus (29%), Eikenella, Bacteroides, Peptostrep |
High rates of infection. Do not close open wounds!
| |
| Rat or pig (polymicrobial, Sprillum minus, Streptobacillus) |
| |
| Lymphadenitis |
Localized infection: GAS, S. aureus (MRSA)...less likely anaerobes, M. Tb (scrofula), Toxoplasmosis, Tularemia, Sporotrichosis,;atypical mycobacterial (consider the latter if nonresponsive to antimicrobials) |
MSSA: Augmentin 90mg/kg/day PO div BID OR Cephalexin 100mg/kg/day PO div QID x10 days. If IV needed, cefazolin 100mg/kg/day IV div Q8. MRSA: Clindamycin OR TMP-SMX OR linezolid OR vancomycin (age based dosing) x7-10 days total. |
| Cat-scratch disease: Bartonella henslae |
Lymphadenitis common in axillary/epitrochlear nodes (46%), neck (26%), inguinal (17%). Treat for immunocompromised host of signs of systemic illness;(HSM).
May also use Bactrim, rifampin and ciprofloxacin. Duration of therapy is uncertain. | |
Orthopedic Infections
Osteomyelitis
| Risk Factor | Likely Organism | Initial Empiric Antibiotic Therapy' |
| Elderly, hematogenous spread | MRSA, MSSA, gram neg | Vancomycin 1gm + (Piperacillin/Tazobactam 3.375 grams OR imipenem 500mg) |
| Sickle Cell Disease | Salmonella, gram-negative bacteria | Ceftriaxone 50mg/kg IV once daily OR Cefotaxime 50mg/kg IV three times daily, PLUS
|
| DM or vascular insufficiency | Polymicrobial: Staph, strep, coliforms, anaerobes | Vancomycin 1gm + (Piperacillin/Tazobactam 3.375 grams OR imipenem 500mg) |
| IV drug user | MRSA, MSSA, pseudomonas | Vancomycin 1gm |
| Newborn | MRSA, MSSA, GBS, Gram Negative | Vancomycin 15mg/kg load, then reduce dose, AND ceftazidime 30mg/kg IV q12 h |
| Children | MRSA, MSSA | Vancomycin 10mg/kg q6 h AND ceftazidime 50mg/kg q8hr |
| Postoperative (ortho) | MRSA, MSSA | Vancomycin 1gm |
| Human bite | Strep, anaerobes, HACEK organism | Piperacillin/Tazobactam 3.375gm OR imipenem 500mg |
| Animal bites | Pasteurella, Eikenella, HACEK organism | Piperacillin/Tazobactam 3.375gm OR imipenem 500mg |
| Foot puncture wound | Pseudomonas | Anti-pseudomonal, staph coverage |
Septic Arthritis
- If immunized against Hib: Nafcillin 200mg/kg/day IV div Q6 OR cefazolin 100mg/kg/day div Q8 x21 days.
- If unimmunized again Hib: Cefuroxime OR cefotaxime AND nafcillin OR cefazolin x21 days.
- If Gonococcus suspected or isolated, ceftriaxone 50mg/kg/day IV/IM daily OR penicillin G IV (if susceptible) x7-10 days.
See Also
Antibiotics by diagnosis
- Bone and joint antibiotics
- Cardiovascular antibiotics
- ENT antibiotics
- Eye antibiotics
- GI antibiotics
- GU antibiotics
- Neuro antibiotics
- OB/GYN antibiotics
- Pulmonary antibiotics
- Skin and soft tissue antibiotics
- Bioterrorism antibiotics
- Environmental exposure antibiotics
- Immunocompromised antibiotics
- Post exposure prophylaxis antibiotics
- Pediatric antibiotics
- Sepsis antibiotics
- Arthropod and parasitic antibiotics
For antibiotics by organism see Microbiology (Main)
References
- ↑ https://www.aappublications.org/content/early/2015/02/25/aapnews.20150225-1
- ↑ Sanford Guide to Antimicrobial Therapy 2014
- ↑ Sanford Guide to Antimicrobial Therapy 2014
- ↑ Sanford Guide to Antimicrobial Therapy 2014
- ↑ Sanford Guide to Antimicrobial Therapy 2014
- ↑ Sanford Guide to Antimicrobial Therapy 2014
- ↑ Sanford Guide to Antimicrobial Therapy 2014
- ↑ Sanford Guide to Antimicrobial Therapy 2014
- ↑ van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702
- ↑ https://www.aappublications.org/content/early/2015/02/25/aapnews.20150225-1
- ↑ Sanford Guide to Antimicrobial Therapy 2014
- ↑ Sanford Guide to Antimicrobial Therapy 2014
- ↑ Sanford Guide to Antimicrobial Therapy 2014
- ↑ Sanford Guide to Antimicrobial Therapy 2014
- ↑ Sanford Guide to Antimicrobial Therapy 2014
- ↑ Sanford Guide to Antimicrobial Therapy 2014
- ↑ Sanford Guide to Antimicrobial Therapy 2014
